Treosulfan-Based Conditioning and Sirolimus-Ptcy Gvhd Prophylaxis in Allogeneic Stem Cell Transplantation for Aggressive B-cell NHL

Key Points

• Improved outcomes are observed with treosulfan-based conditioning and sirolimus-GVHD prophylaxis.
• A significant reduction in GVHD incidence is reported, showing improved patient health after transplantation.
• Assessment using patient records highlights the effectiveness of this dual approach in aggressive B-cell NHL.
• Further validation is needed, as clinical effectiveness is based on single-institution findings, limiting broader applicability.